Bausch Health
BHC
#5111
Rank
S$2.30 B
Marketcap
S$6.16
Share price
0.21%
Change (1 day)
-22.40%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): S-$4.16

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is S-$4.19. In 2025 the company made an earnings per share (EPS) of S$0.54 an increase over its 2024 EPS that were of S-$0.16.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.16-867.4%
2025S$0.54-450%
2024S-$0.16-92.59%
2023S-$2.09160.89%
2022S-$0.80-76.64%
2021S-$3.4368.45%
2020S-$2.04-68.91%
2019S-$6.56-57.11%
2018S-$15.29-272.22%
2017S$8.88-199.29%
2016S-$8.94798.7%
2015S-$0.99-128.31%
2014S$3.51-204.62%
2013S-$3.36602.7%
2012S-$0.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.31-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.23-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA